Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhangzhou Pientzehuang Pharmaceutical., Ltd
  6. Summary
    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/09/2021 06/10/2021 06/11/2021 06/15/2021 06/16/2021 Date
391.13 406.88 404.39 399.36 399.6 Last
7215499 5298027 4363228 3402936 4662102 Volume
+3.75% +4.03% -0.61% -1.24% +0.06% Change
Financials
Sales 2021 7 782 M 1 212 M 1 212 M
Net income 2021 2 170 M 338 M 338 M
Net cash position 2021 6 859 M 1 068 M 1 068 M
P/E ratio 2021 111x
Yield 2021 0,27%
Sales 2022 9 329 M 1 452 M 1 452 M
Net income 2022 2 775 M 432 M 432 M
Net cash position 2022 7 051 M 1 098 M 1 098 M
P/E ratio 2022 88,5x
Yield 2022 0,33%
Capitalization 241 B 37 683 M 37 535 M
EV / Sales 2021 30,1x
EV / Sales 2022 25,1x
Nbr of Employees 2 526
Free-Float 36,5%
More Financials
Company
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL.LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension, bupleurum granules for cold, as well as pharmaceuticals for bone injuries and others.... 
Read more
Sector
Pharmaceuticals
Calendar
08/23Earnings Release
More about the company
Ratings of Zhangzhou Pientzehuang Pharmaceutical., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
01/27EXCLUSIVE : Sinopharm-led consortium plans $3.3 billion take-private of HK-liste..
RE
2020China stocks end lower as high-flying consumer shares retreat
RE
2018LONDON STOCK EXCHANGE : Exclusive - FTSE Russell may give mainland China stocks ..
RE
2018MSCI lists 234 Chinese stocks for index inclusion in boost to capital markets
RE
More news
News in other languages on ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
2020Borsa Shanghai in calo, pesano titoli legati al consumo
More news
Analysis
Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration : Period :
Zhangzhou Pientzehuang Pharmaceutical., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 378,41 CNY
Last Close Price 399,60 CNY
Spread / Highest target 4,93%
Spread / Average Target -5,30%
Spread / Lowest Target -13,8%
EPS Revisions
Managers and Directors
NameTitle
Dong Ming Hong Chairman-Supervisory Board
Jie Pan Chairman
Fei Hong Chief Engineer
Jian Jun Jia Independent Director
Guang Pei Li Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD49.38%37 683
MERCK KGAA7.91%79 795
KYOWA KIRIN CO., LTD.36.11%18 714
SK BIOPHARMACEUTICALS CO., LTD.-26.92%8 645
BETTA PHARMACEUTICALS CO., LTD.-6.30%6 497
YUHAN CORPORATION-15.05%3 728